BridgeBio Pharma, Inc. (BBIO) Discusses Optimistic Part 3 PROPEL 3 Outcomes for Infigratinib in Youngsters With Achondroplasia February 12, 2026 8:00 AM EST
Firm Contributors
Neil Kumar – Co-Founder, CEO & Director
Justin To – CEO of Skeletal Dysplasias
Daniela Rogoff – Chief Medical Officer of Skeletal Dysplasias
Matthew Outten – Chief Business Officer
Convention Name Contributors
Biren Amin – Piper Sandler & Co., Analysis Division
Cory Kasimov – Evercore ISI Institutional Equities, Analysis Division
Mani Foroohar – Leerink Companions LLC, Analysis Division
Salim Syed – Mizuho Securities USA LLC, Analysis Division
Danielle Brill Bongero – Truist Securities, Inc., Analysis Division
Kyuwon Choi – Goldman Sachs Group, Inc., Analysis Division
Lin Tsai – Jefferies LLC, Analysis Division
Eliana Merle – Barclays Financial institution PLC, Analysis Division
Anupam Rama – JPMorgan Chase & Co, Analysis Division
Presentation
Operator
Good day. I will probably be your convention operator immediately. (Operator Directions)
Earlier than we start, I want to remind everybody that immediately’s name might include forward-looking statements throughout the that means of the federal securities legal guidelines, together with, however not restricted to, the statements about BridgeBio’s future working and monetary efficiency, enterprise plans and prospects and technique. These statements are based mostly on present expectations and assumptions which can be topic to dangers and uncertainties which might trigger precise outcomes to vary materially from these expressed or implied in these forward-looking statements. For a dialogue of those dangers and uncertainties, please discuss with the disclosure in immediately’s earnings launch and BridgeBio’s periodic stories and SEC filings. All statements made listed here are based mostly on info accessible to BridgeBio as of immediately, and the corporate undertakes no obligation to replace any forward-looking statements made throughout this name, besides as required by regulation.
With that accomplished, BridgeBio, you might start your convention.
Neil Kumar
Co-Founder, CEO & Director
Thanks, operator, and because of everybody for becoming a member of this name. Along with our unimaginable